CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy: Prime time already?
December 12, 2018 –Â The application of CRISPR/Cas9 based molecular technology in the field of gene editing (or genome editing) has recently had its exploded limelight exposure for a couple of reasons. The question arises if this exposure is earned or …
CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy: Prime time already? Read more »